Pippa

Renal ST5 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Clinical Research Fellow with UoD & AZ 💉Frailty/Multimorbidity/Supportive Care/ Health Inequalities in Renal Disease 🫘 she/her

[Pippa @pippaKT]

My day is now exponentially better having seen this picture that someone on Facebook posted of their hamster having an abdo ultrasound 🐹

[NDT @NDTsocial]

Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial

https://t.co/ox7do25IVu

[AJKD @AJKDonline]

Frailty in Kidney Disease: A Comprehensive Review to Advance Its Clinical and Research Applications

https://t.co/uLjmidJzTN (FREE)

@devimol @DocForGrandma @Rasheeda_HallMD @VUMCKidney @DukeKidney

[KDIGO @goKDIGO]

Today is #IgANAwarenessDay! KDIGO is joining clinicians, patients, and researchers worldwide in raising awareness of IgA Nephropathy (#IgAN).

Check out KDIGO IgAN resources below, and stay tuned for the KDIGO 2025 IgAN Guideline--coming this fall!

Key Messages in IgAN: https://t.co/B59sfNlWWi
KDIGO IgAN Guideline Work Group Members highlight evolving therapies, updated diagnostic strategies, and challenges in managing special populations, offering a preview of what’s to come in the KDIGO 2025 IgAN Guideline.

Updates in IgAN: https://t.co/6nqDLaQaYR
KDIGO IgAN Guideline Co-Chairs Brad Rovin and Jürgen Floege discuss emerging research, new therapies, and practical strategies to improve care.

KDIGO IgAN Infographic: https://t.co/cl25KQLMoa
Get a quick overview of key recommendations from the upcoming KDIGO IgAN Guideline with this easy-to-follow infographic.

[ASN Publications @asnpublications]

Green nephrology, or sustainable nephrology, is gaining interest due to its environmental impact, but there is a lack of original research and data available, requiring further education and research, according to a Review in #ASNCJASN. 10.2215/CJN.0000000731

[Jasmine Sethi @JasmineNephro]

🫘🎯Approach to hemodialysis catheter related blood stream infection

@AJKDonline core curriculum

https://t.co/4AFT4Upkgl

[Pippa @pippaKT]

@fletchjack Hi Jack, if you’re still active on here.. looking for some ideas from other doctors’ messes that have been done up to inspire ours in Tayside. Please pop me a quick message if you have a moment - would really appreciate it :)

[The UK Kidney Association @UKKidney]

🎉Distinguished nephrologist @DavidCWheeler2 has been awarded the prestigious O’Donoghue Lecture!🌟

His pioneering CKD research places him in the top 1% of global researchers by citation. Prof Wheeler will deliver the lecture at #UKKW25

Read more: https://t.co/NHn6rQbgMA

[Jasmine Sethi @JasmineNephro]

🫘✅Sparsentan in IgA Nephropathy

Dual Endothelin Angiotension Receptor antagonist

🔥🔥PROTECT trial

@ISNkidneycare

[Dr. Hardik Patel 🩺💉 @hardik4u24]

Cirrhosis & Kidney: A Dangerous Duo

AKI→ AKD→ CKD isn’t just renal; it’s hepatic too

Up to 50% with cirrhosis develop AKI & upto 25% may progress to CKD

Spot it early, act fast

#NephTwitter #Nephrology #Hepatology #MedEd #Cirrhosis #AKI #CKD

🔗https://t.co/GC7Q3fi2Me 🆕 🆓

[Jasmine Sethi @JasmineNephro]

🫘Causes of AKI in Hypercalcemia

✅Direct renal vasoconstriction

✅Defect in urine concentration due to downregulation of aquaporin-polyuria-pre renal AKI

✅Hypercalcemia induced vomiting-Pre renal AKI

@ISNkidneycare

[Jasmine Sethi @JasmineNephro]

👍New Lupus Nephritis guidelines

#ACR2024

🤘Major change-Triple therapy for induction ✅

[KDIGO @goKDIGO]

Persistent itch in dialysis patients is more than a nuisance—it’s a serious symptom that affects quality of life, sleep, and mental health. Two free, on-demand CME webinars explore how to better recognize and manage chronic kidney disease–associated pruritus (#CKDaP) in clinical practice.

Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
Dr. James Burton and Dr. Carol Pollock share real-world cases and practical strategies for identifying and treating CKD-aP in patients receiving hemodialysis.
Learn more: https://t.co/rKTnTria1M

Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Dr. Jörg Latus highlights the burden of CKD-aP on sleep and mental health and the role of shared decision-making in improving patient outcomes.
Learn more: https://t.co/2RInJt6EA1

#itch #dialysis #pruritus

[Jasmine Sethi @JasmineNephro]

🔥Approach to Autosomal dominant tubulointerstitial kidney disease (ADTKD)

@NDTsocial @hjanders_hans

https://t.co/vCh7LNYidr

[Hans-Joachim Anders @hjanders_hans]

Now online in @NDTsocial

The evolving spectrum of kidney amyloidosis

🧐 Advances in diagnosis, typing and treatment

▶️https://t.co/yJM17Uql2y

[Dr. Hardik Patel 🩺💉 @hardik4u24]

Antiphospholipid Syndrome (APS): The Silent Thrombophilia

From molecular pathogenesis to devastating thrombotic complications—#APS is a ticking time bomb! ⏳🧬

📖 APS review: https://t.co/hd09LbBEax (2025)

#Nephrology #Thrombosis #Lupus #MedTwitter #Rheumatology #Autoimmune

[Jasmine Sethi @JasmineNephro]

✌️Cirrhosis and Ascites

By @TinaPhamHang

[Elba Medina @elbaonelida]

Recognize and Mitigate the Contrast Associated AKI @goKDIGO @NephJC infographic by @JasmineNephro

[Dr. Hardik Patel 🩺💉 @hardik4u24]

🧬 This #AKI diagnostic flowchart is a game-changer—uncover glomerulonephritis🫘, rhabdomyolysis, & more with targeted tests.

Must-know for every nephrologist! 🔍

📖https://t.co/7iETqkAJ7Y

#Nephrology #MedEd #CriticalCare #NephX

[Jasmine Sethi @JasmineNephro]

🎯🫘Novel oral anticoagulant dosing in CKD

@AJKDonline

https://t.co/XbeMuBmRxd

[NDT @NDTsocial]

Upcoming drug targets for kidney protective effects in chronic kidney disease

🆓https://t.co/jwah5Fbr6k